D. Boral Capital Begins Coverage on QT Imaging (NASDAQ:QTI)

Stock analysts at D. Boral Capital initiated coverage on shares of QT Imaging (NASDAQ:QTI) in a research note issued on Friday, Benzinga reports. The firm set a “buy” rating and a $9.00 price target on the stock. D. Boral Capital‘s target price indicates a potential upside of 300.00% from the stock’s previous close.

QTI has been the topic of a number of other reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of QT Imaging in a research report on Tuesday, October 6th. Craig Hallum assumed coverage on shares of QT Imaging in a report on Monday, October 5th. They issued a “buy” rating and a $8.00 price target for the company. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $8.50.

QT Imaging Price Performance

QTI stock traded down $0.11 during midday trading on Friday, reaching $2.25. 40,627 shares of the company’s stock traded hands, compared to its average volume of 40,864. The company has a 50-day simple moving average of $2.67 and a two-hundred day simple moving average of $3.97. QT Imaging has a 1-year low of $2.25 and a 1-year high of $8.50. The company has a market cap of $30.98 million, a price-to-earnings ratio of -1.43 and a beta of 0.02. The company has a quick ratio of 2.06, a current ratio of 3.10 and a debt-to-equity ratio of 6.81.

QT Imaging (NASDAQ:QTI) last released its quarterly earnings results on Wednesday, August 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.53). QT Imaging had a negative net margin of 77.25% and a negative return on equity of 1,202.69%. The business had revenue of $7.44 million during the quarter, compared to the consensus estimate of $7.60 million. On average, analysts anticipate that QT Imaging will post -1.11 earnings per share for the current year.

Institutional Trading of QT Imaging

Institutional investors and hedge funds have recently made changes to their positions in the business. Stonepine Capital Management LLC acquired a new position in shares of QT Imaging in the 2nd quarter valued at $407,000. BlackRock Inc. boosted its position in shares of QT Imaging by 116.5% in the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock worth $250,000 after purchasing an additional 33,009 shares during the last quarter. Finally, Polar Asset Management Partners Inc. bought a new position in shares of QT Imaging in the 2nd quarter worth $210,000. Institutional investors own 24.19% of the company’s stock.

About QT Imaging

QT Imaging Holdings, Inc develops medical imaging technology designed to support breast cancer screening and diagnostic procedures. The company’s flagship product, QTscan, is a three-dimensional, transmission-based breast imaging system that uses ultrasound technology to produce images without ionizing radiation, breast compression or injectable contrast agents.

QTscan is intended for use by healthcare providers as an imaging tool for evaluating breast tissue, including in patients with dense breasts.